347740 — P&K Skin Research Center Co Income Statement

0.000.00%

Last trade - 00:00

IndustrialsAdventurousMicro CapContrarian

Annual income statement for P&K Skin Research Center Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	17,487	17,957	14,843	17,847	22,783
Cost of Revenue
Gross Profit	11,298	11,113	7,199	8,476	10,712
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	11,025	12,317	13,463	15,264	18,890
Operating Profit	6,462	5,640	1,379	2,582	3,893
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	8,526	8,190	5,357	6,797	5,751
Provision for Income Taxes
Net Income After Taxes	7,293	7,130	4,700	5,701	4,604
Minority Interest
Net Income Before Extraordinary Items
Net Income	7,293	7,130	4,813	5,816	4,685
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	7,293	7,130	4,813	5,816	4,685
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	246	239	160	200	163
Dividends per Share